Celgene CEO Weighs In On Receptos Deal And Its Timing


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Celgene Corporation (NASDAQ: CELG) announced on Tuesday that it will be acquiring Receptos Inc (NASDAQ: RCPT) in a $7.3 billion deal.

Robert Hugin, Celgene chairman and CEO, was on CNBC Wednesday to weigh in on the deal and its timing.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Ozanimod: Key Driver

"Exciting time for us and, I think, there are a couple of drugs in the pipeline, but clearly the Ozanimod is the key driver here," Hugin said. "And it has been sort of through a lot of risks and trials already, and the mechanism is been proven [sic.] by other compounds. So, it's very exciting for us."

'Now Is The Time To Strike'

On the timing of the deal, Hugin said, "We really think the operating momentum of the company is so strong, and that's one of the reasons why the timing works on this deal and [...]we preannounced our second-quarter results. Twenty-two (22) percent year-over-year revenue growth, 37 percent year-over-year earnings growth. So, very strong operating performance. Now is the time to strike, build for the future."

Excited About Promise Of The Future

"Over this past couple of months, we have been able to identify and execute three significant deals that really enhance our long-term growth prospects. And not just for the next five or six years, but the next 10 or 15 years.

"We are building our franchises and really focused about doing that and we are just so excited about the promise of the future," Hugin concluded.

Image Credit: Public Domain

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: BiotechCNBCHealth CareTop StoriesMediaOzanimodRobert Hugin